- Home
- IMCR vs NWBI Comparison
IMCR vs NWBI Comparison
Compare IMCR & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- NWBI
- Stock Information
- Founded
- IMCR 2008
- NWBI 1896
- Country
- IMCR United Kingdom
- NWBI United States
- Employees
- IMCR N/A
- NWBI N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- NWBI Major Banks
- Sector
- IMCR Health Care
- NWBI Finance
- Exchange
- IMCR Nasdaq
- NWBI Nasdaq
- Market Cap
- IMCR 1.7B
- NWBI 1.8B
- IPO Year
- IMCR 2021
- NWBI N/A
- Fundamental
- Price
- IMCR $34.26
- NWBI $12.47
- Analyst Decision
- IMCR Buy
- NWBI Hold
- Analyst Count
- IMCR 9
- NWBI 1
- Target Price
- IMCR $57.00
- NWBI $15.00
- AVG Volume (30 Days)
- IMCR 287.1K
- NWBI 845.6K
- Earning Date
- IMCR 11-05-2025
- NWBI 10-27-2025
- Dividend Yield
- IMCR N/A
- NWBI 6.42%
- EPS Growth
- IMCR N/A
- NWBI 39.35
- EPS
- IMCR N/A
- NWBI 1.12
- Revenue
- IMCR $356,145,000.00
- NWBI $561,855,000.00
- Revenue This Year
- IMCR $29.71
- NWBI $6.98
- Revenue Next Year
- IMCR $11.27
- NWBI $11.67
- P/E Ratio
- IMCR N/A
- NWBI $11.13
- Revenue Growth
- IMCR 26.78
- NWBI 14.22
- 52 Week Low
- IMCR $23.15
- NWBI $10.75
- 52 Week High
- IMCR $39.33
- NWBI $15.42
- Technical
- Relative Strength Index (RSI)
- IMCR 49.34
- NWBI 50.01
- Support Level
- IMCR $33.92
- NWBI $12.32
- Resistance Level
- IMCR $37.00
- NWBI $12.80
- Average True Range (ATR)
- IMCR 1.45
- NWBI 0.22
- MACD
- IMCR -0.06
- NWBI -0.00
- Stochastic Oscillator
- IMCR 39.78
- NWBI 39.47
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.